Teacher Retirement System of Texas Sells 38,229 Shares of Hims & Hers Health, Inc. (NYSE:HIMS)

Teacher Retirement System of Texas decreased its holdings in Hims & Hers Health, Inc. (NYSE:HIMS) by 59.4% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 26,093 shares of the company’s stock after selling 38,229 shares during the period. Teacher Retirement System of Texas’ holdings in Hims & Hers Health were worth $771,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also made changes to their positions in the business. Summit Securities Group LLC purchased a new stake in Hims & Hers Health in the fourth quarter valued at $38,000. UMB Bank n.a. boosted its position in Hims & Hers Health by 247.5% in the 1st quarter. UMB Bank n.a. now owns 1,310 shares of the company’s stock valued at $39,000 after buying an additional 933 shares during the period. Fifth Third Bancorp boosted its position in Hims & Hers Health by 165.4% in the 1st quarter. Fifth Third Bancorp now owns 1,542 shares of the company’s stock valued at $46,000 after buying an additional 961 shares during the period. Tsfg LLC acquired a new stake in shares of Hims & Hers Health in the 1st quarter valued at $46,000. Finally, US Bancorp DE grew its stake in Hims & Hers Health by 346.7% during the 4th quarter. US Bancorp DE now owns 1,943 shares of the company’s stock worth $47,000 after buying an additional 1,508 shares during the last quarter. 63.52% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Hims & Hers Health

In other Hims & Hers Health news, CFO Oluyemi Okupe sold 23,107 shares of the company’s stock in a transaction dated Monday, June 23rd. The shares were sold at an average price of $47.25, for a total transaction of $1,091,805.75. Following the transaction, the chief financial officer directly owned 63,222 shares in the company, valued at approximately $2,987,239.50. This represents a 26.77% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Michael Chi sold 17,102 shares of the company’s stock in a transaction dated Tuesday, June 17th. The shares were sold at an average price of $59.75, for a total value of $1,021,844.50. Following the completion of the sale, the insider directly owned 278,654 shares of the company’s stock, valued at approximately $16,649,576.50. This trade represents a 5.78% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 655,433 shares of company stock worth $34,064,594 in the last 90 days. Corporate insiders own 17.71% of the company’s stock.

Hims & Hers Health Stock Performance

Shares of HIMS opened at $51.98 on Tuesday. Hims & Hers Health, Inc. has a twelve month low of $13.47 and a twelve month high of $72.98. The firm has a market cap of $11.63 billion, a PE ratio of 75.33, a PEG ratio of 1.76 and a beta of 2.02. The firm’s 50 day moving average price is $53.88 and its 200 day moving average price is $41.31.

Hims & Hers Health (NYSE:HIMS) last posted its quarterly earnings results on Monday, May 5th. The company reported $0.20 earnings per share for the quarter, topping analysts’ consensus estimates of $0.12 by $0.08. Hims & Hers Health had a net margin of 9.24% and a return on equity of 22.75%. The firm had revenue of $586.01 million for the quarter, compared to the consensus estimate of $535.21 million. During the same quarter in the previous year, the company earned $0.05 earnings per share. The business’s revenue was up 110.7% compared to the same quarter last year. On average, sell-side analysts anticipate that Hims & Hers Health, Inc. will post 0.29 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the stock. Morgan Stanley reaffirmed an “equal weight” rating and issued a $40.00 target price on shares of Hims & Hers Health in a report on Wednesday, June 11th. Truist Financial set a $45.00 price objective on shares of Hims & Hers Health in a research report on Tuesday, June 24th. Wall Street Zen lowered shares of Hims & Hers Health from a “buy” rating to a “hold” rating in a report on Saturday. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating on shares of Hims & Hers Health in a research note on Wednesday, May 7th. Finally, Bank of America increased their price objective on shares of Hims & Hers Health from $22.00 to $26.00 and gave the stock an “underperform” rating in a report on Tuesday, April 29th. Three analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company. According to MarketBeat, Hims & Hers Health presently has a consensus rating of “Hold” and an average price target of $39.58.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.